Kauko, OttoTurunen, MikkoPihlajamaa, PäiviHäkkinen, AnttiQueiroz, Rayner M. L.Pääkkönen, MirvaVentelä, SamiGaetani, MassimilianoLundström, Susanna L.Murgia, AntonioSahu, BiswajyotiRoutila, JohannesWei, Gong-HongIrjala, HeikkiGriffin, Julian L.Lilley, Kathryn S.Kivioja, TeemuHautaniemi, SampsaTaipale, Jussi2025-11-202025-08Kauko, O, Turunen, M, Pihlajamaa, P, Häkkinen, A, Queiroz, R M L, Pääkkönen, M, Ventelä, S, Gaetani, M, Lundström, S L, Murgia, A, Sahu, B, Routila, J, Wei, G-H, Irjala, H, Griffin, J L, Lilley, K S, Kivioja, T, Hautaniemi, S & Taipale, J 2025, 'Diverse oncogenes use common mechanisms to drive growth of major forms of human cancer', Science Advances, vol. 11, no. 34, eadt1798. https://doi.org/10.1126/sciadv.adt17982375-2548RIS: urn:59C788B4E2AB8942D4D8D250EAE02FFEORCID: /0000-0003-1336-7744/work/197805698https://hdl.handle.net/2164/26459We thank Q. Zhang and S. Miettinen for technical assistance, K. Kurppa for critical review of the manuscript, and J. Klefström for valuable suggestions. Tumor proteomics analyses were performed at the Turku Proteomics Facility, University of Turku, and Åbo Akademi University. The facility is supported by Biocenter Finland. We thank the Sequencing Unit of Institute for Molecular Medicine Finland FIMM Technology Centre and Biomedicum Functional Genomics Unit (FuGU) at University of Helsinki for sequencing and microarray services. FIMM Sequencing Unit is supported by Biocenter Finland. The Chemical Proteomics core facility at Biomedicum (MBB, Karolinska Institute), also the Unit of SciLifeLab and part of the Swedish National Infrastructure for Biological Mass Spectrometry (BioMS), provided full support in the experimental design and performance of the proteomics using the PISA assay, with relative data analysis.201575685engSDG 3 - Good Health and Well-beingR Medicine (General)Supplementary DataDASLinkR1Diverse oncogenes use common mechanisms to drive growth of major forms of human cancerJournal article10.1126/sciadv.adt1798